• Mon news: Ventyx gets boost from Sanofi. PhRMA IRA legal challenge gets new life. AZ breast cancer drug disappoints. Teva’s once-monthly schizophrenia med. AZ gets FDA approval for first self-administered flu vaccine. See more on our front page

Stock trouble...


<































yes, that's ketchup boy's and JR strategy, buy, sell, destroy, talk a good game, confuse the investors with double talk and restated FS. I wonder when the sec will catch on.
 




























plunging like a post-burrito power dump! Really, great job by the ever inculpable senior management.

Check your signal-to-noise ratio. Management is investing for the long-term. Do not let the short-term fluctuations faze your judgment. Since 2012, the company has created over $40bn in shareholder value.
 




















Similar threads

Replies
1
Views
634
Novartis
anonymous
Replies
141
Views
37K
Novartis
anonymous
Replies
22
Views
3K
Novartis
anonymous